Showing results (851-860 of 1,396) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|December 21, 2023
Role of Apparent Diffusion Coefficient Map-Based First- and High-Order Radiomic Features for the Discrimination of Sacral Chordomas and Chondrosarcomas With Overlapping Conventional Imaging FeaturesBehrang Amini, Liu Chenglei, Elvis Duran-Sierra, et al.
JCO Precision Oncology|December 21, 2023
Pathogenic Germline Mutational Landscape in Patients With Renal Cell Carcinoma and Associated Clinicopathologic FeaturesCharles B Nguyen, Claire Knaus, Jinju Li, et al.
JCO Precision Oncology|February 27, 2024
Incorporating Genetic Risk Into Prostate Cancer Care: Implications for Early Detection and Precision OncologyAndrew E Amini, Keyan Salari
JCO Precision Oncology|February 27, 2024
Cancer Risks Associated With TP53 Pathogenic Variants: Maximum Likelihood Analysis of Extended Pedigrees for Diagnosis of First Cancers Beyond the Li-Fraumeni Syndrome SpectrumCristina Fortuno, Bing-Jian Feng, Courtney Carroll, et al.
JCO Precision Oncology|December 7, 2023
Endometrial Cancer Risk Among Germline BRCA1/2 Pathogenic Variant Carriers: Review of Our Current Understanding and Next StepsKimia Sorouri, Filipa Lynce, Colleen M Feltmate, et al.
JCO Precision Oncology|November 16, 2023
Amplification of Wild-Type RET Represents a Novel Molecular Subtype of Several Cancer Types With Clinical Response to SelpercatinibMalini M Gandhi, Biagio Ricciuti, Guilherme Harada, et al.
JCO Precision Oncology|November 16, 2023
Dual Prognostic Classification of Triple-Negative Breast Cancer by DNA Damage Immune Response and Homologous Recombination DeficiencyShane R Stecklein, William Barlow, Lajos Pusztai, et al.
JCO Precision Oncology|July 16, 2024
Transcriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography: A Multicenter Retrospective StudyJohn Nikitas, Kritika Subramanian, Nimrod Barashi Gozal, et al.
JCO Precision Oncology|July 16, 2024
Differences in 21-Gene and PAM50 Recurrence Scores in Younger and Black Women With Breast CancerSarah C Van Alsten, Sanah N Vohra, Joannie M Ivory, et al.
JCO Precision Oncology|July 10, 2024
Quantitative Integrative Survival Prediction in Multiple Myeloma Patients Treated With Bortezomib-Based Induction, High-Dose Therapy and Autologous Stem Cell TransplantationManuela Hummel, Thomas Hielscher, Martina Emde-Rajaratnam, et al.
Pageof 140